Use of immunomodulatory therapy as part of comprehensive treatment of non-severe community-acquired pneumonia and its long-term results

Mikhail P Kostinov, Vilia V Gainitdinova, Svetlana V Kazharova, Anna E Vlasenko, Vflentina B Polishchuk, Kirill V Mashilov

Article Type

Original Research

Published

This work aims to study the effectiveness of two different types of immunomodulators for the treatment of non-severe community-acquired pneumonia and assesses the long-term effects of the treatment conducted.

Read more

Open-label use of an aliphatic polyamine immunomodulator in patients hospitalized with COVID-19

Sergey V Efimov, Natallia V Matsiyeuskaya, Olga V Boytsova, Luydmila Yu Akhieva, Elena V Kuntsevich, Anastasia A Troshina, Elena I Kvasova, Anton A Tikhonov, Nadezhda F Khomyakova, Francisco Harrison, Jean-François Rossi, Timothy C Hardman

Article Type

Original Research

Published

This study evaluated the safety and efficacy of azoximer bromide when used in combination with standard of care treatment in patients hospitalized with COVID-19.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.